305 related articles for article (PubMed ID: 37630248)
1. Natural and Synthetic Anticancer Epidrugs Targeting the Epigenetic Integrator UHRF1.
Ashraf W; Ahmad T; Reynoird N; Hamiche A; Mély Y; Bronner C; Mousli M
Molecules; 2023 Aug; 28(16):. PubMed ID: 37630248
[TBL] [Abstract][Full Text] [Related]
2. Signalling pathways in UHRF1-dependent regulation of tumor suppressor genes in cancer.
Alhosin M; Omran Z; Zamzami MA; Al-Malki AL; Choudhry H; Mousli M; Bronner C
J Exp Clin Cancer Res; 2016 Nov; 35(1):174. PubMed ID: 27839516
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of UHRF1, associated with re-expression of tumor suppressor genes, is a common feature of natural compounds exhibiting anti-cancer properties.
Alhosin M; Sharif T; Mousli M; Etienne-Selloum N; Fuhrmann G; Schini-Kerth VB; Bronner C
J Exp Clin Cancer Res; 2011 Apr; 30(1):41. PubMed ID: 21496237
[TBL] [Abstract][Full Text] [Related]
4. UHRF1 Induces Methylation of the
Kim MJ; Lee HJ; Choi MY; Kang SS; Kim YS; Shin JK; Choi WS
Mol Cells; 2021 Mar; 44(3):146-159. PubMed ID: 33795533
[TBL] [Abstract][Full Text] [Related]
5. Thymoquinone Is a Multitarget Single Epidrug That Inhibits the UHRF1 Protein Complex.
Abdullah O; Omran Z; Hosawi S; Hamiche A; Bronner C; Alhosin M
Genes (Basel); 2021 Apr; 12(5):. PubMed ID: 33922029
[TBL] [Abstract][Full Text] [Related]
6. [Role of UHRF1 in methylation regulation and angiogenesis].
Guo Z; Mo Z
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Feb; 37(2):200-204. PubMed ID: 32034755
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of
Beck A; Trippel F; Wagner A; Joppien S; Felle M; Vokuhl C; Schwarzmayr T; Strom TM; von Schweinitz D; Längst G; Kappler R
Clin Epigenetics; 2018; 10():27. PubMed ID: 29507645
[TBL] [Abstract][Full Text] [Related]
8. UHRF1 depletion and HDAC inhibition reactivate epigenetically silenced genes in colorectal cancer cells.
Niinuma T; Kitajima H; Kai M; Yamamoto E; Yorozu A; Ishiguro K; Sasaki H; Sudo G; Toyota M; Hatahira T; Maruyama R; Tokino T; Nakase H; Sugai T; Suzuki H
Clin Epigenetics; 2019 May; 11(1):70. PubMed ID: 31064417
[TBL] [Abstract][Full Text] [Related]
9. UHRF1 promotes proliferation of gastric cancer via mediating tumor suppressor gene hypermethylation.
Zhou L; Shang Y; Jin Z; Zhang W; Lv C; Zhao X; Liu Y; Li N; Liang J
Cancer Biol Ther; 2015; 16(8):1241-51. PubMed ID: 26147747
[TBL] [Abstract][Full Text] [Related]
10. UHRF1 is a mediator of KRAS driven oncogenesis in lung adenocarcinoma.
Kostyrko K; Román M; Lee AG; Simpson DR; Dinh PT; Leung SG; Marini KD; Kelly MR; Broyde J; Califano A; Jackson PK; Sweet-Cordero EA
Nat Commun; 2023 Jul; 14(1):3966. PubMed ID: 37407562
[TBL] [Abstract][Full Text] [Related]
11. The finger loop of the SRA domain in the E3 ligase UHRF1 is a regulator of ubiquitin targeting and is required for the maintenance of DNA methylation.
Vaughan RM; Rothbart SB; Dickson BM
J Biol Chem; 2019 Oct; 294(43):15724-15732. PubMed ID: 31481468
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic repression of regulator of G-protein signaling 2 by ubiquitin-like with PHD and ring-finger domain 1 promotes bladder cancer progression.
Ying L; Lin J; Qiu F; Cao M; Chen H; Liu Z; Huang Y
FEBS J; 2015 Jan; 282(1):174-82. PubMed ID: 25323766
[TBL] [Abstract][Full Text] [Related]
13. Targeting microRNA/UHRF1 pathways as a novel strategy for cancer therapy.
Choudhry H; Zamzami MA; Omran Z; Wu W; Mousli M; Bronner C; Alhosin M
Oncol Lett; 2018 Jan; 15(1):3-10. PubMed ID: 29285183
[TBL] [Abstract][Full Text] [Related]
14. UHRF1 downregulation promotes T follicular helper cell differentiation by increasing BCL6 expression in SLE.
Liu L; Hu L; Yang L; Jia S; Du P; Min X; Wu J; Wu H; Long H; Lu Q; Zhao M
Clin Epigenetics; 2021 Feb; 13(1):31. PubMed ID: 33568199
[TBL] [Abstract][Full Text] [Related]
15. Upregulated UHRF1 promotes bladder cancer cell invasion by epigenetic silencing of KiSS1.
Zhang Y; Huang Z; Zhu Z; Zheng X; Liu J; Han Z; Ma X; Zhang Y
PLoS One; 2014; 9(10):e104252. PubMed ID: 25272010
[TBL] [Abstract][Full Text] [Related]
16. The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progression.
Babbio F; Pistore C; Curti L; Castiglioni I; Kunderfranco P; Brino L; Oudet P; Seiler R; Thalman GN; Roggero E; Sarti M; Pinton S; Mello-Grand M; Chiorino G; Catapano CV; Carbone GM; Bonapace IM
Oncogene; 2012 Nov; 31(46):4878-87. PubMed ID: 22330138
[TBL] [Abstract][Full Text] [Related]
17. Discovery and Mechanism of Small Molecule Inhibitors Selective for the Chromatin-Binding Domains of Oncogenic UHRF1.
Liu WH; Miner RE; Albaugh BN; Ananiev GE; Wildman SA; Denu JM
Biochemistry; 2022 Mar; 61(5):354-366. PubMed ID: 35143176
[TBL] [Abstract][Full Text] [Related]
18. Defining UHRF1 Domains that Support Maintenance of Human Colon Cancer DNA Methylation and Oncogenic Properties.
Kong X; Chen J; Xie W; Brown SM; Cai Y; Wu K; Fan D; Nie Y; Yegnasubramanian S; Tiedemann RL; Tao Y; Chiu Yen RW; Topper MJ; Zahnow CA; Easwaran H; Rothbart SB; Xia L; Baylin SB
Cancer Cell; 2019 Apr; 35(4):633-648.e7. PubMed ID: 30956060
[TBL] [Abstract][Full Text] [Related]
19. Structure-based screening combined with computational and biochemical analyses identified the inhibitor targeting the binding of DNA Ligase 1 to UHRF1.
Kori S; Shibahashi Y; Ekimoto T; Nishiyama A; Yoshimi S; Yamaguchi K; Nagatoishi S; Ohta M; Tsumoto K; Nakanishi M; Defossez PA; Ikeguchi M; Arita K
Bioorg Med Chem; 2021 Dec; 52():116500. PubMed ID: 34801826
[TBL] [Abstract][Full Text] [Related]
20. PHD finger recognition of unmodified histone H3R2 links UHRF1 to regulation of euchromatic gene expression.
Rajakumara E; Wang Z; Ma H; Hu L; Chen H; Lin Y; Guo R; Wu F; Li H; Lan F; Shi YG; Xu Y; Patel DJ; Shi Y
Mol Cell; 2011 Jul; 43(2):275-284. PubMed ID: 21777816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
